Products - Psoriasis | Topic | NICE

Showing 7 products

Date | Title

Status: Topic selectionRemove ‘Status: Topic selection’ filter

CT-P43 (ustekinumab biosimilar) for treating moderate to severe plaque psoriasis TS ID 11773
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
ABP-654 (ustekinumab biosimilar) for previously treated moderate to severe plaque psoriasis TS ID 11790
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Intravenous infusion of mesenchymal stromal cells in patients with severe recalcitrant psoriasis
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Apremilast for treating moderate to severe plaque psoriasis in people aged 6 to 17 TS ID 11921
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Intravenous infusion of mesenchymal stromal cells in patients with severe recalcitrant psoriasis
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Secukinumab biosimilar for treating plaque psoriasis TSID 11992
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Guselkumab for treating chronic plaque psoriasis in children aged 6 to 17 years TSID 12002
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC